Could an antibiotic boost breast cancer treatment? phase 3 trial results awaited
NCT ID NCT05114720
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 24 times
Summary
This phase 3 trial tested whether adding the antibiotic moxifloxacin to standard chemotherapy helps prevent breast cancer from returning after surgery. 559 people with operable breast cancer took part. The study compared disease-free survival between those who got moxifloxacin and those who got a placebo alongside their chemo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.